0001104659-15-030980.txt : 20150428 0001104659-15-030980.hdr.sgml : 20150428 20150428160437 ACCESSION NUMBER: 0001104659-15-030980 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150424 FILED AS OF DATE: 20150428 DATE AS OF CHANGE: 20150428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sabba Stephen L CENTRAL INDEX KEY: 0001442372 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 15798584 MAIL ADDRESS: STREET 1: DORSET MANAGEMENT CORP STREET 2: 485 UNDERHILL BLVD SUITE 205 CITY: SYOSSET STATE: NY ZIP: 11791 4/A 1 a4a.xml 4/A X0306 4/A 2015-04-24 2014-10-10 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001442372 Sabba Stephen L DORSET MANAGEMENT CORP 485 UNDERHILL BLVD SUITE 205 SYOSSET NY 11791 1 0 0 0 Common Stock 2015-04-24 4 A 0 925 0.00 A 26622 D Non-Qualified Stock Option (right to buy) 89.75 2015-04-24 4 A 0 2754 0.00 A 2025-04-24 Common Stock 2754 2754 D Non-Qualified Stock Option (right to buy) 67.53 2024-06-04 Common Stock 3312 3312 D These securities, as represented in Column 5, include a grant of 925 restricted shares acquired by a grant of the Board of Directors of the Company at the 2015 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date. These securities, as represented in Column 5, were acquired by a grant of 2,754 shares by the Board of Directors of the Company at the 2015 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time. These securities were previously reported on a Form 4 for this Reporting Person filed on June 6, 2014, and are included on this Form 4 only to report that as of June 4, 2015, they will be fully vested and exercisable. In addition to the new awards reflected on this filing, this filing is being made to correct the number of securiites in column 5 of Table I, which reflects shares previously reported on the Form 4 filing made on November 14, 2011. /s/Stephen L. Sabba 2015-04-28